Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Riam Shammaa

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Frontiers in Medicine|December 9, 2021
Cell Therapy: Types, Regulation, and Clinical BenefitsAbed El-Hakim El-Kadiry, Moutih Rafei, Riam Shammaa
Frontiers in Bioengineering and Biotechnology|April 9, 2020
Intralesional Injection of Bone Marrow Aspirate Concentrate for the Treatment of Osteonecrosis of the Knee Secondary to Systemic Lupus Erythematosus: A Case ReportDimitrios Kouroupis, Amir F Ahari, Diego Correa, et al.
Frontiers in Cell and Developmental Biology|March 6, 2020
Mesenchymal Stem Cells Beyond Regenerative MedicineRiam Shammaa, Abed El-Hakim El-Kadiry, Jamilah Abusarah, et al.
Frontiers in Medicine|April 5, 2021
Autologous BMAC Therapy Improves Spinal Degenerative Joint Disease in Lower Back Pain PatientsAbed El-Hakim El-Kadiry, Carlos Lumbao, Moutih Rafei, et al.
BMC Musculoskeletal Disorders|January 4, 2022
Bone marrow aspirate concentrate versus platelet-rich plasma for treating knee osteoarthritis: a one-year non-randomized retrospective comparative studyAbed El-Hakim El-Kadiry, Carlos Lumbao, Natasha Salame, et al.
Cells|February 25, 2022
Humoral Immunity to Allogeneic Immunoproteasome-Expressing Mesenchymal Stromal Cells Requires Efferocytosis by Endogenous PhagocytesJean-Pierre Bikorimana, Jamilah Abusarah, Natasha Salame, et al.
Cells|July 27, 2022
CD146 Defines a Mesenchymal Stromal Cell Subpopulation with Enhanced Suppressive PropertiesJean-Pierre Bikorimana, Wael Saad, Jamilah Abusarah, et al.
Iscience|November 28, 2022
The <i>CIt</i> protocol: A blueprint to potentiate the immunogenicity of immunoproteasome-reprogrammed mesenchymal stromal cellsJean-Pierre Bikorimana, Nehme El-Hachem, Jamilah Abusarah, et al.
Cells|June 10, 2022
LSD1 Inhibition Enhances the Immunogenicity of Mesenchymal Stromal Cells by Eliciting a dsRNA Stress ResponseFatemeh Mardani, Wael Saad, Nehme El-Hachem, et al.
Frontiers in Immunology|February 5, 2021
Thymoproteasome-Expressing Mesenchymal Stromal Cells Confer Protective Anti-Tumor Immunity <i>via</i> Cross-Priming of Endogenous Dendritic CellsJean-Pierre Bikorimana, Nehme El-Hachem, Abed El-Hakim El-Kadiry, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Frontiers in Medicine|December 9, 2021
Cell Therapy: Types, Regulation, and Clinical BenefitsAbed El-Hakim El-Kadiry, Moutih Rafei, Riam Shammaa
Frontiers in Bioengineering and Biotechnology|April 9, 2020
Intralesional Injection of Bone Marrow Aspirate Concentrate for the Treatment of Osteonecrosis of the Knee Secondary to Systemic Lupus Erythematosus: A Case ReportDimitrios Kouroupis, Amir F Ahari, Diego Correa, et al.
Frontiers in Cell and Developmental Biology|March 6, 2020
Mesenchymal Stem Cells Beyond Regenerative MedicineRiam Shammaa, Abed El-Hakim El-Kadiry, Jamilah Abusarah, et al.
Frontiers in Medicine|April 5, 2021
Autologous BMAC Therapy Improves Spinal Degenerative Joint Disease in Lower Back Pain PatientsAbed El-Hakim El-Kadiry, Carlos Lumbao, Moutih Rafei, et al.
BMC Musculoskeletal Disorders|January 4, 2022
Bone marrow aspirate concentrate versus platelet-rich plasma for treating knee osteoarthritis: a one-year non-randomized retrospective comparative studyAbed El-Hakim El-Kadiry, Carlos Lumbao, Natasha Salame, et al.
Cells|February 25, 2022
Humoral Immunity to Allogeneic Immunoproteasome-Expressing Mesenchymal Stromal Cells Requires Efferocytosis by Endogenous PhagocytesJean-Pierre Bikorimana, Jamilah Abusarah, Natasha Salame, et al.
Cells|July 27, 2022
CD146 Defines a Mesenchymal Stromal Cell Subpopulation with Enhanced Suppressive PropertiesJean-Pierre Bikorimana, Wael Saad, Jamilah Abusarah, et al.
Iscience|November 28, 2022
The <i>CIt</i> protocol: A blueprint to potentiate the immunogenicity of immunoproteasome-reprogrammed mesenchymal stromal cellsJean-Pierre Bikorimana, Nehme El-Hachem, Jamilah Abusarah, et al.
Cells|June 10, 2022
LSD1 Inhibition Enhances the Immunogenicity of Mesenchymal Stromal Cells by Eliciting a dsRNA Stress ResponseFatemeh Mardani, Wael Saad, Nehme El-Hachem, et al.
Frontiers in Immunology|February 5, 2021
Thymoproteasome-Expressing Mesenchymal Stromal Cells Confer Protective Anti-Tumor Immunity <i>via</i> Cross-Priming of Endogenous Dendritic CellsJean-Pierre Bikorimana, Nehme El-Hachem, Abed El-Hakim El-Kadiry, et al.
Pageof 2